NFKB1 and congenital rubella syndrome: In addition, higenamine was also found to significantly inhibit the protein expression of mitogen-activated protein kinase (MAPK) (ERK and P38)/NF-κB pathway in CRS rats and then to protect rat cardiomyocytes [30].